Accera Inc., of Boulder, Colo., and Duchembio Co. Ltd., of Seoul, South Korea, said they entered a strategic partnership and exclusive licensing agreement in which Duchembio will obtain rights to develop, obtain regulatory approval and commercialize products in South Korea using Accera's medium chain triglyceride technology. Financial terms were not disclosed.